Exact Imaging officials describe the approach behind FusionVu as an easy, cost-effective “cognitive assist” for the urologist. The urologist can quickly import radiological reports from MRI scans or import the annotated MR images themselves. FusionVu aligns the scans with their MRI-identified images with the live ExactVu micro-ultrasound images. Most of the time, urologists will still identify and target lesions using PRI-MUS and ExactVu, but when needed, they’ll be able to leverage the MRI-identified lesions to make sure they don’t miss them during the total biopsy procedure. The FusionVu application runs on the
Because the FusionVu application runs on the ExactVu platform, no new hardware or radiological software is needed. It also does not interfere with the urological workflow, according to Exact Imaging.
“At least 70% of prostate cancer is located in the peripheral zone, which is exquisitely visualized and targetable with the 70-micron resolution of the ExactVu micro-ultrasound system,” Exact Imaging President and CEO Randy AuCoin said in a news release. “Our evidence-based PRI-MUS protocol is easily applied to help urologists identify and characterize regions and then to target those suspicious regions. For the minority of cases, such as patients with previous negative biopsies or those with exclusive anterior lesions, Exact Imaging is introducing its FusionVu micro-US/MRI fusion solution. The ExactVu micro-ultrasound platform with FusionVu is a total urological solution and is easily upgradable, scalable and provides a smart, practical investment pathway for urologists.”
Exact Imaging will be showing off both FusionVu and ExactVu at Booth #D10 at the EAU (European Association of Urology) 2017 Annual Congress in London, March 25–27.
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]